{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-045748","form_type":"8-K","ticker":"NKTR","cik":"0000906709","company_name":"NEKTAR THERAPEUTICS","filed_at":"2023-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.742762+00:00","generated_at":"2026-06-14T08:47:20.081629+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Nektar receives Nasdaq notice for non-compliance with $1.00 minimum bid price rule","bullets":["Notice dated May 26, 2023; stock closed below $1.00 for 30 consecutive business days.","Company has until November 22, 2023 to regain compliance by closing at $1.00+ for 10 consecutive days.","If not compliant, may qualify for second 180-day period by transferring to Nasdaq Capital Market.","Company intends to monitor bid price and evaluate options including possible reverse stock split.","No immediate impact on listing; delisting possible if compliance not achieved."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-045748","json":"https://secwatch.observer/filing/0001213900-23-045748.json","markdown":"https://secwatch.observer/filing/0001213900-23-045748.md","text":"https://secwatch.observer/filing/0001213900-23-045748.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/906709/000121390023045748/0001213900-23-045748-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/906709/000121390023045748/ea179697-8k_nektar.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T08:47:20.081629+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"78288c9e258086f0d7b3bec4a0b19c6c800f5273","claim":"NEKTAR THERAPEUTICS received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).","evidence_excerpt":"May 26, 2023, Nektar Therapeutics (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Global Select Market (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”) because the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days. The Notice has no immediate effect on the Nasdaq listing or trading of the Company’s common stock. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Com","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/906709/000121390023045748/0001213900-23-045748-index.htm","confidence":0.98,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}